Prof. John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society of Hematology (ASH) Annual Meeting about current strategies for managing mantle cell lymphoma in the clinic. Topics include approaches to prolong progression-free survival; patient tolerability of aggressive approaches; treatment resistance; and novel biologic therapies.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates